“We're drowning and we're alone”: a qualitative study of the lived experience of people experiencing persistent post-COVID-19 symptoms
D Goodridge, TN Lowe, S Cai, FN Herriot… - … Open Access Journal, 2023 - cmajopen.ca
Background The “long tail” of the COVID-19 pandemic will be reflected in disabling symptoms
that persist, fluctuate or recur for extended periods for an estimated 20%–30% of those …
that persist, fluctuate or recur for extended periods for an estimated 20%–30% of those …
[HTML][HTML] Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an …
…, E Ogburn, J Allen, H Rutter, N Francis, NPB Thomas… - The Lancet, 2023 - thelancet.com
Background The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …
Relative alignment between the magnetic field and molecular gas structure in the vela c giant molecular cloud using low-and high-density tracers
We compare the magnetic field orientation for the young giant molecular cloud Vela C inferred
from 500 μm polarization maps made with the BLASTPol balloon-borne polarimeter to the …
from 500 μm polarization maps made with the BLASTPol balloon-borne polarimeter to the …
[HTML][HTML] Clinical exome sequencing of 1000 families with complex immune phenotypes: toward comprehensive genomic evaluations
…, A Borges, N Gentile, J Niemela, C Lowe… - Journal of Allergy and …, 2022 - Elsevier
Background Prospective genetic evaluation of patients at our referral research hospital
presents clinical research challenges. Objective This study sought not only a single-gene …
presents clinical research challenges. Objective This study sought not only a single-gene …
[HTML][HTML] Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients
…, NM Rahman, LM Yu, NPB Thomas… - Nature …, 2024 - nature.com
Viral clearance, antibody response and the mutagenic effect of molnupiravir has not been
elucidated in at-risk populations. Non-hospitalised participants within 5 days of SARS-CoV-2 …
elucidated in at-risk populations. Non-hospitalised participants within 5 days of SARS-CoV-2 …
International perspectives on patient involvement in clinical trials in nephrology
…, R Lowe-Jones, S Damster, N Thomas… - Kidney …, 2020 - kidney-international.org
The involvement of patients in nephrology clinical trials is limited despite their ability to prioritize
research, help with study design, participation, and implementation of results. The aim of …
research, help with study design, participation, and implementation of results. The aim of …
Biophilic Institutions: Building New Solidarities between the Economy & Nature
N Iskander, N Lowe - Dædalus, 2023 - direct.mit.edu
… Nichola Lowe is Professor of City and Regional Planning at the University of North
Carolina at Chapel Hill. She is the author of Putting Skill to Work: How to Create Good Jobs in …
Carolina at Chapel Hill. She is the author of Putting Skill to Work: How to Create Good Jobs in …
Platform adaptive trial of novel antivirals for early treatment of COVID-19 in the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive …
…, M Benysek, MI Andersson, N Francis, NPB Thomas… - BMJ open, 2023 - bmjopen.bmj.com
Introduction There is an urgent need to determine the safety, effectiveness and cost-effectiveness
of novel antiviral treatments for COVID-19 in vaccinated patients in the community at …
of novel antiviral treatments for COVID-19 in vaccinated patients in the community at …
Response to desmopressin in type IID von Willebrand's disease
N Thomas, U O'CALLAGHAN… - Clinical & Laboratory …, 1989 - Wiley Online Library
Dominant transmission of a variant of von Willebrand's disease (vWD) with aberrant
polymerization of von Willebrand factor (vWF) has been identified in a Scottish family. Multimer …
polymerization of von Willebrand factor (vWF) has been identified in a Scottish family. Multimer …
Molnupiravir Treatment for COVID-19 in People at Higher Risk in the Community: Outcomes from the PANORAMIC Randomised Controlled Trial at Three and Six …
Objectives: Treating COVID-19 infection with antiviral drugs may reduce the longer-term
impact of the illness, but no randomised controlled trials have yet reported on the effectiveness …
impact of the illness, but no randomised controlled trials have yet reported on the effectiveness …
